FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3103554383> ?p ?o ?g. }

• W3103554383 endingPage "314" @default.
• W3103554383 startingPage "304" @default.
• W3103554383 abstract "Objective Epilepsy develops in 70 to 90% of children with tuberous sclerosis complex (TSC) and is often resistant to medication. Recently, the concept of preventive antiepileptic treatment to modify the natural history of epilepsy has been proposed. EPISTOP was a clinical trial designed to compare preventive versus conventional antiepileptic treatment in TSC infants. Methods In this multicenter study, 94 infants with TSC without seizure history were followed with monthly video electroencephalography (EEG), and received vigabatrin either as conventional antiepileptic treatment, started after the first electrographic or clinical seizure, or preventively when epileptiform EEG activity before seizures was detected. At 6 sites, subjects were randomly allocated to treatment in a 1:1 ratio in a randomized controlled trial (RCT). At 4 sites, treatment allocation was fixed; this was denoted an open-label trial (OLT). Subjects were followed until 2 years of age. The primary endpoint was the time to first clinical seizure. Results In 54 subjects, epileptiform EEG abnormalities were identified before seizures. Twenty-seven were included in the RCT and 27 in the OLT. The time to the first clinical seizure was significantly longer with preventive than conventional treatment [RCT: 364 days (95% confidence interval [CI] = 223–535) vs 124 days (95% CI = 33–149); OLT: 426 days (95% CI = 258–628) vs 106 days (95% CI = 11–149)]. At 24 months, our pooled analysis showed preventive treatment reduced the risk of clinical seizures (odds ratio [OR] = 0.21, p = 0.032), drug-resistant epilepsy (OR = 0.23, p = 0.022), and infantile spasms (OR = 0, p < 0.001). No adverse events related to preventive treatment were noted. Interpretation Preventive treatment with vigabatrin was safe and modified the natural history of seizures in TSC, reducing the risk and severity of epilepsy. ANN NEUROL 2021;89:304–314" @default.
• W3103554383 created "2020-11-23" @default.
• W3103554383 creator A5001185202 @default.
• W3103554383 creator A5002398450 @default.
• W3103554383 creator A5003603164 @default.
• W3103554383 creator A5005178459 @default.
• W3103554383 creator A5005801531 @default.
• W3103554383 creator A5008350546 @default.
• W3103554383 creator A5010278316 @default.
• W3103554383 creator A5015383974 @default.
• W3103554383 creator A5028077452 @default.
• W3103554383 creator A5033436532 @default.
• W3103554383 creator A5036395814 @default.
• W3103554383 creator A5040114021 @default.
• W3103554383 creator A5047558085 @default.
• W3103554383 creator A5052752045 @default.
• W3103554383 creator A5054279276 @default.
• W3103554383 creator A5056140727 @default.
• W3103554383 creator A5059140601 @default.
• W3103554383 creator A5061158845 @default.
• W3103554383 creator A5062218837 @default.
• W3103554383 creator A5067401650 @default.
• W3103554383 creator A5068559486 @default.
• W3103554383 creator A5074767492 @default.
• W3103554383 creator A5076205740 @default.
• W3103554383 creator A5081255561 @default.
• W3103554383 creator A5082410934 @default.
• W3103554383 creator A5084704668 @default.
• W3103554383 date "2020-11-27" @default.
• W3103554383 modified "2023-10-14" @default.
• W3103554383 title "Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the <scp>EPISTOP</scp> Trial" @default.
• W3103554383 cites W1520014842 @default.
• W3103554383 cites W1886226115 @default.
• W3103554383 cites W1920696238 @default.
• W3103554383 cites W1969184353 @default.
• W3103554383 cites W1976871747 @default.
• W3103554383 cites W1978437325 @default.
• W3103554383 cites W1996556344 @default.
• W3103554383 cites W2026430274 @default.
• W3103554383 cites W2041842123 @default.
• W3103554383 cites W2062000411 @default.
• W3103554383 cites W2063309568 @default.
• W3103554383 cites W2066284829 @default.
• W3103554383 cites W2080090598 @default.
• W3103554383 cites W2092491756 @default.
• W3103554383 cites W2101002011 @default.
• W3103554383 cites W2105558792 @default.
• W3103554383 cites W2126467306 @default.
• W3103554383 cites W2137971072 @default.
• W3103554383 cites W2162084088 @default.
• W3103554383 cites W2176205911 @default.
• W3103554383 cites W2518546995 @default.
• W3103554383 cites W2608937503 @default.
• W3103554383 cites W2766143571 @default.
• W3103554383 cites W2889830295 @default.
• W3103554383 cites W2900828529 @default.
• W3103554383 cites W2941119008 @default.
• W3103554383 cites W2948816809 @default.
• W3103554383 cites W2960633981 @default.
• W3103554383 cites W2962973903 @default.
• W3103554383 cites W2980350053 @default.
• W3103554383 cites W2982862638 @default.
• W3103554383 cites W4256397550 @default.
• W3103554383 doi "https://doi.org/10.1002/ana.25956" @default.
• W3103554383 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7898885" @default.
• W3103554383 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33180985" @default.
• W3103554383 hasPublicationYear "2020" @default.
• W3103554383 type Work @default.
• W3103554383 sameAs 3103554383 @default.
• W3103554383 citedByCount "111" @default.
• W3103554383 countsByYear W31035543832020 @default.
• W3103554383 countsByYear W31035543832021 @default.
• W3103554383 countsByYear W31035543832022 @default.
• W3103554383 countsByYear W31035543832023 @default.
• W3103554383 crossrefType "journal-article" @default.
• W3103554383 hasAuthorship W3103554383A5001185202 @default.
• W3103554383 hasAuthorship W3103554383A5002398450 @default.
• W3103554383 hasAuthorship W3103554383A5003603164 @default.
• W3103554383 hasAuthorship W3103554383A5005178459 @default.
• W3103554383 hasAuthorship W3103554383A5005801531 @default.
• W3103554383 hasAuthorship W3103554383A5008350546 @default.
• W3103554383 hasAuthorship W3103554383A5010278316 @default.
• W3103554383 hasAuthorship W3103554383A5015383974 @default.
• W3103554383 hasAuthorship W3103554383A5028077452 @default.
• W3103554383 hasAuthorship W3103554383A5033436532 @default.
• W3103554383 hasAuthorship W3103554383A5036395814 @default.
• W3103554383 hasAuthorship W3103554383A5040114021 @default.
• W3103554383 hasAuthorship W3103554383A5047558085 @default.
• W3103554383 hasAuthorship W3103554383A5052752045 @default.
• W3103554383 hasAuthorship W3103554383A5054279276 @default.
• W3103554383 hasAuthorship W3103554383A5056140727 @default.
• W3103554383 hasAuthorship W3103554383A5059140601 @default.
• W3103554383 hasAuthorship W3103554383A5061158845 @default.
• W3103554383 hasAuthorship W3103554383A5062218837 @default.
• W3103554383 hasAuthorship W3103554383A5067401650 @default.
• W3103554383 hasAuthorship W3103554383A5068559486 @default.
• W3103554383 hasAuthorship W3103554383A5074767492 @default.
• W3103554383 hasAuthorship W3103554383A5076205740 @default.

• next